- Home
- BNS vs ZTS Comparison
BNS vs ZTS Comparison
Compare BNS & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNS
- ZTS
- Stock Information
- Founded
- BNS 1832
- ZTS 1952
- Country
- BNS Canada
- ZTS United States
- Employees
- BNS N/A
- ZTS N/A
- Industry
- BNS
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- BNS
- ZTS Health Care
- Exchange
- BNS Nasdaq
- ZTS Nasdaq
- Market Cap
- BNS 68.3B
- ZTS 73.2B
- IPO Year
- BNS N/A
- ZTS 2013
- Fundamental
- Price
- BNS $55.20
- ZTS $148.53
- Analyst Decision
- BNS Hold
- ZTS Buy
- Analyst Count
- BNS 2
- ZTS 8
- Target Price
- BNS $77.50
- ZTS $204.00
- AVG Volume (30 Days)
- BNS 2.5M
- ZTS 2.9M
- Earning Date
- BNS 08-26-2025
- ZTS 08-05-2025
- Dividend Yield
- BNS 5.56%
- ZTS 1.35%
- EPS Growth
- BNS N/A
- ZTS 7.32
- EPS
- BNS 3.46
- ZTS 5.57
- Revenue
- BNS $21,114,182,735.00
- ZTS $9,286,000,000.00
- Revenue This Year
- BNS $26.09
- ZTS $3.45
- Revenue Next Year
- BNS $4.14
- ZTS $6.16
- P/E Ratio
- BNS $15.95
- ZTS $26.66
- Revenue Growth
- BNS N/A
- ZTS 6.32
- 52 Week Low
- BNS $43.68
- ZTS $139.70
- 52 Week High
- BNS $57.07
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- BNS 60.99
- ZTS 29.66
- Support Level
- BNS $54.32
- ZTS $156.26
- Resistance Level
- BNS $55.34
- ZTS $161.77
- Average True Range (ATR)
- BNS 0.51
- ZTS 3.34
- MACD
- BNS -0.11
- ZTS -0.82
- Stochastic Oscillator
- BNS 59.15
- ZTS 6.63
About BNS Bank Nova Scotia Halifax Pfd 3
Bank of Nova Scotia is a global financial services provider with over CAD 1.4 trillion in assets. The bank has four major business segments: Canadian banking, international banking, global wealth management, and global banking and markets. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in the Latin America region.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.